novartis' growth outlook & key markets : vasant narasimhan exclusive | global dialogues | cnbc-tv18
Published 1 year ago • 147 plays • Length 11:29Download video MP4
Download video MP3
Similar videos
-
26:21
vas narasimhan discusses novartis's india strategy, growth outlook | global dialogues | cnbc-tv18
-
0:57
novartis global ceo vas narasimhan: ai's impact on pharma and clinical trial realities | n18s
-
3:45
novartis not joining the 'frenzy' of weight loss drugs, ceo says
-
3:43
novartis ceo vas narasimhan on the latest research on a breast cancer drug
-
5:44
it's likely the fed will cut less than people expect, says hps investment's purnima puri
-
1:17
activist investor starboard value take $1 billion stake in pfizer
-
25:17
novartis ceo vas narasimhan: how to be a boss in an “unbossed” company
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
3:01
novartis ceo vas narasimhan: strategic approach to weight-loss drug development | n18v | cnbc tv18
-
11:11
investing $400 million annually into india: novartis global ceo vasant narasimhan | cnbc tv18
-
14:37
novartis' long-standing india presence & expectations from big pharma: vasant narasimhan exclusive
-
3:30
in a decade from now, a.i. could help change healthcare: novartis ceo vas narasimhan | n18v
-
11:13
novartis ceo narasimhan on growth prospects, pandemic disruption
-
3:29
innovative medicines business returning to growth, novartis ceo says
-
4:54
novartis ceo: confident about continued sales growth for rest of year
-
4:16
novartis ceo vas narasimhan: our medicines are starting to take market share and deliver on promises
-
12:38
health care in a post-pandemic world with vas narasimhan novartis at cnbc evolve global summit 2021
-
6:12
novartis ceo: expect continued growth in 2023
-
10:36
what are the key stocks & sectors in focus today? | cnbc tv18
-
1:58
novartis raises outlook after sandoz generics spinoff
-
1:16
ashhish vaidya explains how singaporean capital fuels india's growth | india singapore connect
-
7:51
watch cnbc's full interview with novartis ceo vas narasimhan